Inhibition of long-term potentiation by NMDA-mediated nitric oxide release.

Activation of N-methyl-D-aspartate (NMDA) receptors before tetanic stimulation blocks long-term potentiation (LTP) in the CA1 region of the hippocampus. This NMDA-mediated inhibition of LTP can be reversed by the nitric oxide (NO) inhibitors L-NG-monomethyl-arginine or hemoglobin and mimicked by sodium nitroprusside. These results indicate that the timing of NO release relative to high-frequency activation of CA1 synapses may be an important determinant of LTP generation and suggest that NO may play a positive or negative modulatory role in LTP depending on prior events at the tetanized synapse and the ambient concentration of excitatory amino acids.

[1]  A. Lowenthal,et al.  THE FREE AMINO ACIDS IN HUMAN CEREBROSPINAL FLUID , 1970, Journal of neurochemistry.

[2]  G. Lynch,et al.  Intracellular injections of EGTA block induction of hippocampal long-term potentiation , 1983, Nature.

[3]  V. Abraira,et al.  In vivo determination of extracellular concentration of amino acids in the rat hippocampus. A method based on brain dialysis and computerized analysis , 1986, Brain Research.

[4]  W. Martin,et al.  The mechanisms by which haemoglobin inhibits the relaxation of rabbit aorta induced by nitrovasodilators, nitric oxide, or bovine retractor penis inhibitory factor , 1986, British journal of pharmacology.

[5]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[6]  T. Bliss,et al.  Long-term potentiation in the dentate gyrus: induction and increased glutamate release are blocked by d(−)aminophosphonovalerate , 1987, Neuroscience.

[7]  S. Moncada,et al.  L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. , 1988, Biochemical and biophysical research communications.

[8]  R. Nicoll,et al.  NMDA application potentiates synaptic transmission in the hippocampus , 1988, Nature.

[9]  J. Garthwaite,et al.  Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain , 1988, Nature.

[10]  G. Collingridge,et al.  Low-frequency activation of the NMDA receptor system can prevent the induction of LTP , 1989, Neuroscience Letters.

[11]  A. Gibson,et al.  l‐NG‐nitro arginine (l‐NOARG), a novel, l‐arginine‐reversible inhibitor of endothelium‐dependent vasodilatation in vitro , 1990, British journal of pharmacology.

[12]  C. Stevens,et al.  Presynaptic mechanism for long-term potentiation in the hippocampus , 1990, Nature.

[13]  G. Edelman,et al.  The NO hypothesis: possible effects of a short-lived, rapidly diffusible signal in the development and function of the nervous system. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Snyder,et al.  Localization of nitric oxide synthase indicating a neural role for nitric oxide , 1990, Nature.

[15]  R. Tsien,et al.  Presynaptic enhancement shown by whole-cell recordings of long-term potentiation in hippocampal slices , 1990, Nature.

[16]  Robert C. Malenka,et al.  Postsynaptic factors control the duration of synaptic enhancement in area CA1 of the hippocampus , 1991, Neuron.

[17]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[18]  B. McNaughton,et al.  Long‐term enhancement of CA1 synaptic transmission is due to increased quantal size, not quantal content , 1991, Hippocampus.

[19]  S. Snyder,et al.  Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Snyder,et al.  Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase , 1991, Neuron.

[21]  G. Böhme,et al.  Possible involvement of nitric oxide in long-term potentiation. , 1991, European journal of pharmacology.

[22]  E. Kandel,et al.  Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Madison,et al.  A requirement for the intercellular messenger nitric oxide in long-term potentiation. , 1991, Science.

[24]  J. Garthwaite,et al.  NMDA receptor activation in rat hippocampus induces cyclic GMP formation through the l-arginine-nitric oxide pathway , 1991, Neuroscience Letters.

[25]  D. Clifford,et al.  Nitric oxide inhibitors attenuate N-methyl-d-aspartate excitotoxicity in rat hippocampal slices , 1992, Neuroscience Letters.

[26]  O. Manzoni,et al.  Nitric oxide-induced blockade of NMDA receptors , 1992, Neuron.

[27]  R. Malenka,et al.  The influence of prior synaptic activity on the induction of long-term potentiation. , 1992, Science.

[28]  R. Nicoll,et al.  Postsynaptic contribution to long-term potentiation revealed by the analysis of miniature synaptic currents , 1992, Nature.

[29]  George L. Wilcox,et al.  The role of nitric oxide in hippocampal long-term potentiation , 1992, Neuron.

[30]  D. Clifford,et al.  Low concentrations of N-methyl-d-aspartate inhibit the induction of long-term potentiation in rat hippocampal slices , 1992, Neuroscience Letters.